Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice
Ist Teil von
Journal of neuroimmunology, 2006-02, Vol.171 (1), p.8-16
Ort / Verlag
Netherlands: Elsevier B.V
Erscheinungsjahr
2006
Quelle
MEDLINE
Beschreibungen/Notizen
We have investigated the efficacy of immunization against peptides from predisposing MHC class II molecules in human-compatible adjuvants for ameliorating experimental autoimmune myasthenia gravis (EAMG). C57BL/6 mice were immunized three times with the peptide I-Aβ
b62–76 in Alum
+
killed pertussis organisms (PT) prior to two injections with
tAChR. The treatment greatly reduced the occurrence and severity of clinical MG relative to controls that received saline/Alum
+
PT or none. It also reduced antibody and T-cell responses against
tAChR. The results have important implications for the possible immunotherapy of MG by targeting disease-associated MHC.